A polymorphism in the CYP17 gene and risk of prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 3, 2002, Pages 243-247

  Stanford, Janet L ^a,b   Noonan, Elizabeth A ^a   Iwasaki, Lori ^a   Kolb, Suzanne ^a   Chadwick, Robert B ^c   Feng, Ziding ^a   Ostrander, Elaine A ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON BOTHELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CYTOCHROME P450C17; STEROID HORMONE; TESTOSTERONE;

ADULT; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DNA DETERMINATION; FAMILIAL CANCER; FAMILY HISTORY; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HOMOZYGOSITY; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RISK ASSESSMENT; TESTOSTERONE SYNTHESIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANDROGENS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; WASHINGTON;

EID: 0036223318     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cancer statistics, 2001
2. Cloning and sequence of the human gene for P450c17 (steroid 17 a-hydroxylase/17,20 lyase): Similarity with the gene for p450c21
3. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene. CYP17
4. Sex steroid hormones and genetic susceptibility to breast and prostate cancer
5. Promoter-specific activation of RNA polymerase II transcription by Spl
6. Prostate cancer associated with CYP17 genotype
7. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect
8. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
9. A polymorphism in the CYP17 gene is associated with prostate cancer risk
10. Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5a-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population
11. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer
12. Vasectomy and risk of prostate cancer
13. Sampling methods for random digit dialing
14. Isolation of high-molecular weight DNA from mammalian cells
15. The analysis of case-control studies
16. Risk assessment for case-control subgroups by polychotomous logistic regression
17. Genetic control of human androgen metabolism by the CYP17 and SRD5A2 Genes
18. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
19. Prospective study of sex hormone levels and risk of prostate cancer
20. CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis
21. CYP17 and breast cancer risk: The polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1
22. A polymorphism in the CYP17 gene increases the risk of breast cancer
23. A polymorphism in the CYP17 gene is associated with male breast cancer
24. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
25. Genetics of prostate cancer: Too many loci, too few genes
26. Familial prostate cancer
27. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer